Advertisements

Boehringer Ingelheim strengthens early science portfolio through comprehensive multifaceted partnership with Peking University

Boehringer Ingelheim strengthens early science portfolio through comprehensive multifaceted partnership with Peking University.....»»

Category: press-releasesSource: businesswireindiaMay 17th, 2017

Go for comprehensive health insurance early

Go for comprehensive health insurance early.....»»

Category: topSource: mydigitalfcNov 5th, 2017

Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers

Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers.....»»

Category: press-releasesSource: businesswireindiaMar 2nd, 2017

Boehringer Ingelheim and China Southeast University collaborate to develop new treatment approaches for hearing loss

Boehringer Ingelheim and China Southeast University collaborate to develop new treatment approaches for hearing loss.....»»

Category: press-releasesSource: businesswireindiaNov 29th, 2016

Lupin in pact with Boehringer Ingelheim to market diabetic drug - Livemint

Lupin in pact with Boehringer Ingelheim to market diabetic drug - Livemint.....»»

Category: topSource: googlenewsOct 14th, 2016

Boehringer Ingelheim and University of Dundee collaborate to develop new class of medicines

Boehringer Ingelheim and University of Dundee collaborate to develop new class of medicines.....»»

Category: press-releasesSource: businesswireindiaJul 14th, 2016

Narendra Modi pitches for greater commercial engagement between India, Thailand

Narendra Modi pitches for greater commercial engagement between India, Thailand.....»»

Category: economySource: business-standardJun 17th, 2016

Soon, better performing batteries with improved safety

Soon, better performing batteries with improved safety.....»»

Category: infotechSource: sify3 hr. 16 min. ago

Bharti family pledges Rs7,000 crore to philanthropy

Bharti family pledges Rs7,000 crore to philanthropy.....»»

Category: featuresSource: livemintNov 23rd, 2017

Bharti family pledges Rs 7,000 cr to philanthropy

Bharti family pledges Rs 7,000 cr to philanthropy.....»»

Category: topSource: business-standardNov 23rd, 2017

Boehringer Ingelheim Makes Many of Its Best Molecules Openly Available to the Scientific Community Via opnMe.com To Unlock Their Full Potential

Boehringer Ingelheim Makes Many of Its Best Molecules Openly Available to the Scientific Community Via opnMe.com To Unlock Their Full Potential.....»»

Category: press-releasesSource: businesswireindiaNov 20th, 2017

Key sub-analyses of RE-DUAL PCI™ showed large reductions in the incidence of bleeding complications if Pradaxa® (dabigatran etexilate) dual therapy was used instead of warfarin triple therapy

Key sub-analyses of RE-DUAL PCI™ showed large reductions in the incidence of bleeding complications if Pradaxa® (dabigatran etexilate) dual therapy was used instead of warfarin triple therapy.....»»

Category: press-releasesSource: businesswireindiaNov 16th, 2017

RCEP Summit: As leaders take stage, India not ready on crucial issues

RCEP Summit: As leaders take stage, India not ready on crucial issues.....»»

Category: featuresSource: business-standardNov 13th, 2017

Cyltezo®, adalimumab biosimilar from Boehringer Ingelheim, approved in Europe for the treatment of multiple chronic inflammatory diseases

Cyltezo®, adalimumab biosimilar from Boehringer Ingelheim, approved in Europe for the treatment of multiple chronic inflammatory diseases.....»»

Category: press-releasesSource: businesswireindiaNov 13th, 2017

Headway in services deal unlikely at RCEP summit

Headway in services deal unlikely at RCEP summit.....»»

Category: economySource: livemintNov 12th, 2017

Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases

Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases.....»»

Category: press-releasesSource: businesswireindiaNov 8th, 2017

Young Turks: Axilor Ventures an accelerator seed fund for early stage startups

Young Turks: Axilor Ventures an accelerator seed fund for early stage startups.....»»

Category: topSource: moneycontrolNov 4th, 2017

Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases including Nonalcoholic Steatohepatitis (NASH)

Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases including Nonalcoholic Steatohepatitis (NASH).....»»

Category: press-releasesSource: businesswireindiaNov 2nd, 2017

Boehringer Ingelheim expands collaboration with Sarah Cannon Research Institute to investigate novel immuno-oncology combination therapy

Boehringer Ingelheim expands collaboration with Sarah Cannon Research Institute to investigate novel immuno-oncology combination therapy.....»»

Category: press-releasesSource: businesswireindiaOct 31st, 2017

Reliance Nippon AMC IPO opens today, analysts recommend ‘subscribe’

Reliance Nippon AMC IPO opens today, analysts recommend ‘subscribe’.....»»

Category: economySource: livemintOct 24th, 2017

Rupee strengthens by 11 paise to 64.91

Rupee strengthens by 11 paise to 64.91.....»»

Category: marketsSource: thehindubusinesslineOct 24th, 2017